# PASG (Passage BIO, Inc.) - SEC EDGAR Financial Statements

> Passage BIO, Inc. reported $20.79M in total assets and a net loss of $33.08M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PASG
- Markdown: https://convexityos.com/fundamentals/PASG.md
- SEC CIK: 0001787297
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001787297&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$35.31M | Operating profit |
| Net Income | FY 2025 | -$33.08M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$10.28 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $20.16M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $23.28M | $40.18M | $61.42M | $86.05M | $117.7M | $81.79M | $29.74M |
| **Operating Income** | -$49.30M | -$70.40M | -$108.4M | -$138.4M | -$185.7M | -$112.9M | -$37.19M |
| **EBITDA** | -$48.57M | -$67.32M | -$104.7M | -$134.7M | -$184.2M | -$112.1M | -$37.05M |
| Interest Income | -- | -- | -- | -- | $343K | $670K | $696K |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- |
| **Net Income** | -$45.52M | -$64.77M | -$102.1M | -$136.1M | -$185.4M | -$112.2M | -$45.63M |
| Basic EPS | -$14.35 | -$21.04 | -$36.47 | -$49.02 | -$68.24 | -$57.06 | -$211.18 |
| **Diluted EPS** | -$14.35 | -$21.04 | -$36.47 | -$49.02 | -$68.24 | -$57.06 | -$211.18 |
| Basic Shares Outstanding | 3.2M | 3.1M | 2.8M | 2.8M | 2.7M | 2.0M | 216.0K |
| Diluted Shares Outstanding | 3.2M | 3.1M | 2.8M | 2.8M | 2.7M | 2.0M | 216.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.50M | $3.34M | $4.09M | $5.42M | $4.31M | $5.81M | $7.74M | $9.56M |
| **Operating Income** | -$4.94M | -$8.27M | -$8.25M | -$13.85M | -$8.65M | -$10.33M | -$16.46M | -$14.27M |
| **EBITDA** | -$4.94M | -$8.25M | -$8.12M | -$13.67M | -$8.46M | -$10.13M | -$16.26M | -$13.55M |
| **Net Income** | -$4.72M | -$7.82M | -$7.56M | -$12.98M | -$7.75M | -$9.38M | -$15.40M | -$12.72M |
| Basic EPS | -$1.47 | -$2.44 | -$2.36 | -- | -$2.44 | -$2.96 | -$4.87 | -- |
| **Diluted EPS** | -$1.47 | -$2.44 | -$2.36 | -- | -$2.44 | -$2.96 | -$4.87 | -- |
| Basic Shares Outstanding | 3.2M | 3.2M | 3.2M | -- | 3.2M | 3.2M | 3.2M | -- |
| Diluted Shares Outstanding | 3.2M | 3.2M | 3.2M | -- | 3.2M | 3.2M | 3.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $46.30M | $37.57M | $21.71M | $34.60M | $129.0M | $135.0M | $158.9M |
| Short-Term Investments | $0 | $39.18M | $92.58M | $155.0M | $186.8M | $169.8M | -- |
| **Cash & Short-Term Investments** | $46.30M | $76.76M | $114.3M | $189.6M | $315.8M | $304.8M | $158.9M |
| **Total Current Assets** | $47.76M | $78.81M | $118.0M | $197.0M | $325.1M | $317.2M | $165.8M |
| Property, Plant & Equipment, Net | $4.11M | $9.33M | $15.29M | $22.52M | $23.81M | $2.79M | $1.09M |
| Other Non-Current Assets | $244K | $463K | $433K | $4.27M | $6.20M | $8.03M | $11.75M |
| **Total Non-Current Assets** | $14.52M | $23.60M | $32.59M | $46.51M | $30.01M | $10.82M | $12.84M |
| **Total Assets** | $62.28M | $102.4M | $150.5M | $243.5M | $355.1M | $328.0M | $178.6M |
| Accounts Payable | $1.11M | $742K | $1.30M | $4.07M | $9.45M | $5.26M | $629K |
| Deferred Revenue (Current) | $13.75M | $8.23M | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | $2.00M | -- | $500K | $541K | $46K |
| **Total Current Liabilities** | $23.08M | $19.36M | $16.34M | $18.35M | $29.50M | $21.18M | $3.68M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $41K | $76K |
| **Total Non-Current Liabilities** | $20.44M | $21.79M | $22.92M | $23.83M | $6.92M | $2.12M | $580K |
| **Total Liabilities** | $43.53M | $41.15M | $39.26M | $42.18M | $36.42M | $23.29M | $4.26M |
| **Total Debt (incl. Leases)** | $24.01M | $25.48M | $26.29M | $27.11M | -- | -- | -- |
| Common Stock | -- | $6.0K | $5.0K | $5.0K | $5.0K | $4.0K | -- |
| Retained Earnings | -$704.8M | -$659.2M | -$594.5M | -$492.4M | -$356.3M | -$170.9M | -$58.66M |
| Accumulated Other Comp. Income | -- | $8.0K | -$43K | -$966K | -$413K | -$12K | -- |
| **Total Stockholders' Equity** | $18.75M | $61.26M | $111.3M | $201.4M | $318.7M | $304.7M | -$56.25M |
| Total Equity | $18.75M | $61.26M | $111.3M | $201.4M | $318.7M | $304.7M | -$56.25M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.16M | $24.16M | $33.34M | $46.30M | $52.77M | $57.63M | $63.36M | $37.57M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | -- | $39.18M |
| **Cash & Short-Term Investments** | $20.16M | $24.16M | $33.34M | $46.30M | $52.77M | $57.63M | $63.36M | $76.76M |
| **Total Current Assets** | $20.79M | $25.18M | $34.74M | $47.76M | $55.73M | $60.31M | $66.67M | $78.81M |
| Property, Plant & Equipment, Net | -- | -- | $826K | $4.11M | $5.16M | $5.34M | $5.52M | $9.33M |
| Other Non-Current Assets | -- | -- | $244K | $244K | $270K | $270K | $274K | $463K |
| **Total Non-Current Assets** | $0 | $0 | $1.72M | $14.52M | $18.43M | $18.88M | $19.34M | $23.60M |
| **Total Assets** | $20.79M | $25.18M | $36.46M | $62.28M | $74.16M | $79.20M | $86.01M | $102.4M |
| Accounts Payable | $533K | $902K | $1.31M | $1.11M | $952K | $2.40M | $1.46M | $742K |
| Deferred Revenue (Current) | $17.03M | $16.25M | $13.75M | $13.75M | $13.75M | $9.74M | $8.73M | $8.23M |
| **Total Current Liabilities** | $20.74M | $20.72M | $20.10M | $23.08M | $22.25M | $19.80M | $17.82M | $19.36M |
| **Total Non-Current Liabilities** | $0 | $0 | $4.61M | $20.44M | $20.80M | $21.14M | $21.48M | $21.79M |
| **Total Liabilities** | $20.74M | $20.72M | $24.71M | $43.53M | $43.04M | $40.94M | $39.30M | $41.15M |
| **Total Debt (incl. Leases)** | -- | -- | $5.75M | $24.01M | $24.34M | $24.73M | $25.12M | $25.48M |
| Common Stock | -- | -- | -- | -- | -- | -- | $6.0K | $6.0K |
| Retained Earnings | -$724.9M | -$720.1M | -$712.3M | -$704.8M | -$691.8M | -$684.0M | -$674.6M | -$659.2M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | $8.0K |
| **Total Stockholders' Equity** | $50K | $4.46M | $11.75M | $18.75M | $31.12M | $38.26M | $46.71M | $61.26M |
| Total Equity | $50K | $4.46M | $11.75M | $18.75M | $31.12M | $38.26M | $46.71M | $61.26M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.52M | -$64.77M | -$102.1M | -$136.1M | -$185.4M | -$112.2M | -$45.63M |
| Depreciation & Amortization | $728K | $3.08M | $3.72M | $3.68M | $1.54M | $800K | $134K |
| Stock-Based Compensation | $3.00M | $5.82M | $10.92M | $18.95M | $32.69M | $14.58M | $1.45M |
| Change in Payables | $1.88M | -$556K | -$2.79M | -$5.41M | $2.20M | $4.59M | $398K |
| **Operating Cash Flow** | -$31.51M | -$47.96M | -$78.26M | -$118.2M | -$126.9M | -$80.52M | -$39.90M |
| Capital Expenditure | -- | -$34K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -- | -$47.99M | -- | -- | -- | -- | -- |
| Purchases of Investments | -- | -$88.17M | -$129.4M | -$157.8M | -$202.5M | -$266.1M | -- |
| **Investing Cash Flow** | $40.22M | $54.95M | $65.24M | $25.20M | -$45.81M | -$172.1M | -$1.69M |
| Common Stock Issued | -- | -- | -- | -- | $165.8M | $228.3M | -- |
| **Financing Cash Flow** | $23K | $8.87M | $135K | -$1.35M | $166.7M | $228.8M | $175.6M |
| **Net Change in Cash** | $8.73M | $15.86M | -$12.89M | -$94.36M | -$6.04M | -$23.87M | $134.0M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.72M | -$7.82M | -$7.56M | -$12.98M | -$7.75M | -$9.38M | -$15.40M | -$12.72M |
| Depreciation & Amortization | $0 | $25K | $129K | $177K | $200K | $200K | $201K | $719K |
| Stock-Based Compensation | $313K | $525K | $556K | $609K | $611K | $923K | $858K | $1.25M |
| Change in Payables | -$369K | -$408K | $197K | $161K | $66K | $937K | $716K | -$747K |
| **Operating Cash Flow** | -$4.00M | -$9.18M | -$12.99M | -$6.48M | -$4.85M | -$6.33M | -$13.85M | -$8.44M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -$15.58M |
| **Investing Cash Flow** | $3.0K | $0 | $20K | $0 | $0 | $585K | $39.63M | $13.68M |
| **Financing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $47K |
| **Net Change in Cash** | -$4.00M | -$9.18M | -$12.97M | -$6.47M | -$4.85M | -$5.73M | $25.78M | $5.28M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -242.7% | -105.7% | -91.7% | -67.6% | -58.2% | -36.8% | -- |
| Return on Assets (ROA) | -73.1% | -63.2% | -67.8% | -55.9% | -52.2% | -34.2% | -25.5% |
| Current Ratio | 2.07x | 4.07x | 7.22x | 10.74x | 11.02x | 14.98x | 45.04x |
| Quick Ratio | 2.01x | 3.96x | 6.99x | 10.33x | 10.70x | 14.40x | 43.16x |
| Debt to Equity | 1.28x | 0.42x | 0.24x | 0.13x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -66164.0% | -810.4% | -320.6% | -242.7% | -145.4% | -148.6% | -135.9% | -105.7% |
| Return on Assets (ROA) | -159.1% | -143.4% | -103.3% | -73.1% | -61.0% | -71.8% | -73.8% | -63.2% |
| Current Ratio | 1.00x | 1.22x | 1.73x | 2.07x | 2.51x | 3.05x | 3.74x | 4.07x |
| Quick Ratio | 0.97x | 1.17x | 1.66x | 2.01x | 2.37x | 2.91x | 3.55x | 3.96x |
| Debt to Equity | -- | -- | 0.49x | 1.28x | 0.78x | 0.65x | 0.54x | 0.42x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
